Saliva as a Window Into Cystic Fibrosis: Metabolic Biomarkers and Clinical Potential

Host: Ryan Quigley <br> <p data-end="749" data-start="197">In a 2025 study investigating salivary metabolites as potential biomarkers in cystic fibrosis, researchers identified distinct metabolic patterns linked with key complications as well as correlations with lung function. In this <i>AudioAbstract, </i>Ryan Quigley discusses how a simple saliva sample could provide clinicians with an accessible, non-invasive tool to stratify patients, monitor therapies, and advance personalized care in cystic fibrosis. This topic was also discussed at the 2025 CHEST Annual Meeting.</p>